Back
ESC Premium Access

Tecarfarin pharmacokinetics and pharmacodynamics-A novel CYP2C9 independent vitamin K antagonist

Session: Insights on thrombosis and anticoagulants
Topic: Thrombosis and coagulation
Speaker: Doctor M. Midei (Monkton, US)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mark Midei

Armetheon, Monkton (United States of America)
0 follower

5 more presentations in this session

Familial clustering of venous thromboembolism - A Danish nationwide cohort study

Speaker: Ms C. Clausen (Hellerup, DK)

Access
Abstract
Like
Thumbnail

Inhibitory effects of ticagrelor monotherapy on arachidonic acid induced platelet aggregation in patients with coronary heart disease

Speaker: Doctor J. Jiang (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Contemporary registry of intermediate and high risk pulmonary embolism patients presenting to a large tertiary medical center

Speaker: Doctor R. Beigel (Ramat Gan, IL)

Access
Abstract
Like
Thumbnail

Markers of thrombin generation in patients with ST-elevation myocardial infarction are associated with long term clinical outcome

Speaker: Mrs C. Hansen (Oslo, NO)

Access
Abstract
Slides
Like
Thumbnail

Presence of bacterial DNA in thrombus aspirates of patients with myocardial infarction.

Speaker: Doctor P. Pinon (Pontevedra, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Insights on thrombosis and anticoagulants

Speakers: Doctor M. Midei, Ms C. Clausen, Doctor J. Jiang, Doctor R. Beigel, Mrs C. Hansen...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources